Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nikolaus Marx

Showing results (21-30 of 566) with videos related to

Pageof 57
Sort By:
Trends in Cardiovascular Medicine|March 1, 2008
C-peptide as a mediator of lesion development in early diabetes--a novel hypothesisNikolaus Marx
Deutsche Medizinische Wochenschrift (1946)|November 18, 2017
[Abnormal blood count - how to deal with an altered platelet and leukocytes count]Nikolaus Marx
Deutsche Medizinische Wochenschrift (1946)|October 22, 2014
[Is intensive glycemic control for patients with type 2 diabetes profitable? - Diabetes therapy should be more individualised]Nikolaus Marx
Deutsche Medizinische Wochenschrift (1946)|August 15, 2022
[Valve diseases - new treatment options improve quality of life and prognosis]Nikolaus Marx
Diabetes & Vascular Disease Research|May 13, 2011
A commentary on Diabetic and non-diabetic patients with left main and/ or three-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents by Banning AP et alNikolaus Marx
Deutsche Medizinische Wochenschrift (1946)|April 22, 2017
[Valvular Diseases and Severe Heart Failure: Cooperation in the Heart Team]Nikolaus Marx
Cardiovascular Drugs and Therapy|June 4, 2008
Focussed section "Effect of oral antidiabetic drugs on micro- and macrovascular complications in patients with diabetes mellitus--update 2008"Nikolaus Marx
Deutsche Medizinische Wochenschrift (1946)|April 30, 2015
[Heart and diabetes: the number of high risk patients increases]Nikolaus Marx
Der Internist|November 7, 2019
[Drug treatment of heart failure in chronic kidney disease]Nikolaus Marx
Current Pharmaceutical Design|January 31, 2012
Renin-angiotensin-aldosterone system antagonists and the prevention of type 2 diabetes mellitusRobert Stohr, Nikolaus Marx
Pageof 57

Showing results (21-30 of 566) with videos related to

Sort By:
Pageof 57
Trends in Cardiovascular Medicine|March 1, 2008
C-peptide as a mediator of lesion development in early diabetes--a novel hypothesisNikolaus Marx
Deutsche Medizinische Wochenschrift (1946)|November 18, 2017
[Abnormal blood count - how to deal with an altered platelet and leukocytes count]Nikolaus Marx
Deutsche Medizinische Wochenschrift (1946)|October 22, 2014
[Is intensive glycemic control for patients with type 2 diabetes profitable? - Diabetes therapy should be more individualised]Nikolaus Marx
Deutsche Medizinische Wochenschrift (1946)|August 15, 2022
[Valve diseases - new treatment options improve quality of life and prognosis]Nikolaus Marx
Diabetes & Vascular Disease Research|May 13, 2011
A commentary on Diabetic and non-diabetic patients with left main and/ or three-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents by Banning AP et alNikolaus Marx
Deutsche Medizinische Wochenschrift (1946)|April 22, 2017
[Valvular Diseases and Severe Heart Failure: Cooperation in the Heart Team]Nikolaus Marx
Cardiovascular Drugs and Therapy|June 4, 2008
Focussed section "Effect of oral antidiabetic drugs on micro- and macrovascular complications in patients with diabetes mellitus--update 2008"Nikolaus Marx
Deutsche Medizinische Wochenschrift (1946)|April 30, 2015
[Heart and diabetes: the number of high risk patients increases]Nikolaus Marx
Der Internist|November 7, 2019
[Drug treatment of heart failure in chronic kidney disease]Nikolaus Marx
Current Pharmaceutical Design|January 31, 2012
Renin-angiotensin-aldosterone system antagonists and the prevention of type 2 diabetes mellitusRobert Stohr, Nikolaus Marx
Pageof 57